This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    


Replace Messy Ice Baths

Cool to -60C. Heat to +150C. Designed for laboratory use, TECA cold/hot plates offer convenient thermal control of samples in histology and life sciences applications.



 




NSH NEWS

2-day Carolina Symposium offers new workshops in a gorgeous location
NSH
Building on the success of last year's Carolina Symposium the 2014 Carolina Program Team sought to offer a unique educational opportunity taking advantage not only of great NSH speakers but incorporating local experts from South Carolina that you don't have access to at other meetings. The two-day symposium offers 12 sessions of which six are new and only being offered at this event. In addition to great workshops the event is designed to maximize networking time with fellow attendees and exhibitors. Located in the foothills of the Blue Ridge Mountains and easily accessible by planes, trains and automobiles Greenville, S.C., is an oasis to spend two days learning and enjoying yourself with fellow histotechs. Register today!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




Basic, Quality and Lab Management Webinar — Feb. 20
NSH
Join Donna Willis, HT(ASCP)HTL from Baylor University Medical Center on Feb. 20 for a discussion on the basics of quality and laboratory management, developing department quality management programs and how to maintain those programs in your lab or facility. Learn more.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Histotechnology Professionals Day is only 1 month away!
NSH
March 10 is quickly approaching us and we know you want to celebrate yourself and your employees for the hard work given each and every day. In celebration, NSH will be sponsoring a scavenger hunt and offer free webinars to NSH members! Check out our website for more details. We also have many items to choose from to celebrate your day, click here to see what products are available. Like HPD on Facebook and remember the hashtag: #histoday.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


TOP STORIES


Rewriting the human genome
MIT Technology Review
Over the last decade, as DNA-sequencing technology has grown ever faster and cheaper, our understanding of the human genome has increased accordingly. Yet scientists have until recently remained largely ham-fisted when they've tried to directly modify genes in a living cell. Take sickle-cell anemia, for example. A debilitating and often deadly disease, it is caused by a mutation in just one of a patient's 3 billion DNA base pairs. Even though this genetic error is simple and well studied, researchers are helpless to correct it and halt its devastating effects. Now there is hope in the form of new genome-engineering tools, particularly one called CRISPR.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Chemotherapy then radiation effective against brain tumor
UPI
Those with low-grade gliomas — brain tumors — who received chemotherapy and then radiation lived longer than those who received only radiation, U.S. researchers say. Co-lead investigator Dr. Jan Buckner, professor of oncology at the Mayo Clinic in Rochester, Minn., said all three chemotherapy drugs in the regimen are commercially available, so the treatment used in the clinical trial is available for use.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Reduce Cost with Same Quality

GBI Labs produces the largest selection of secondary detection kits. We provide free samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market. Some 110mL kits cost as little as $700.00 and 18 ml kit > $300.00.
 


'Curry implant' can slow down breast cancer development
Counsel & Heal
Based on several studies, researchers have tied curry to many health benefits. In some of these studies, curry was tied to having anti-cancer properties. However, simply eating curry was not tied to reducing cancer risks. In a new study, researchers from the University of Louisville, Ky. developed a "curry implant" in the form of a dissolvable capsule. The team tested the capsules by implanting them into mice models and discovered that the spice was capable of reducing tumor size.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Vitamin C as a cancer treatment? High doses boost chemotherapy in study
Los Angeles Times
Could pumping roughly 2,000 oranges' worth of vitamin C into a patient's bloodstream boost the effectiveness of anti-cancer drugs and mitigate the grueling side effects of chemotherapy? In research recently published in the journal Science Translational Medicine, scientists found that high doses of vitamin C — administered intravenously — increased the cancer-killing effects of chemotherapy drugs in mice and blunted toxic side effects in humans.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Uterine surgical technique is linked to abnormal growths and cancer spread
The New York Times
Concerns are increasing among doctors about the safety of a procedure performed on tens of thousands of women a year in the United States who undergo surgery to remove fibroid tumors from the uterus, or to remove the entire uterus. The procedure, morcellation, cuts tissue into pieces that can be pulled out through tiny incisions. The technique is part of minimally invasive surgery, which avoids big incisions, shortens recovery time, and reduces the risks of blood loss, infection, and other complications.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Latest advancements in brain cancer R&D
By Rosemary Sparacio
Promising research and development is being accomplished all throughout the oncology field. This includes advances in brain cancer research, which can be seen in areas as diverse as boosting the immune system to innovative surgery. Patients with one of the most aggressive brain cancers — glioblastoma — typically have a survival rate beyond five years of less than 5 percent. But several recent studies have shown advancements in the treatment of this deadly cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  PRODUCT SHOWCASES
Empowering Science with Color Integrity

Datacolor CHROMACAL™ standardizes color reproduction in digital brightfield images.

• Delivers a consistent, reliable basis for evaluation, communication, quantification, documentation and publication
• Includes image and monitor calibration software, along with a proprietary color calibration slide
• Integrates into existing imaging workflow
• Compatible with most microscopes, scientific cameras and acquisition software

LEARN MORE
ergoCentric Laboratory Seating

Visit LabStorage System’s updated website to view details about this new laboratory seating with specially formulated Infection Control coating. Non-porous and easily disinfected, this moisture proof coating is anti-bacterial, anti-fungal and stain resistant. more



To find out how to feature your company in Under the Microscope and other advertising opportunities, Contact Geoffrey Forneret at 469.420.2629

More info


IN THE NEWS


New research aims for better monitoring, treatment for chronic kidney disease
News-Medical.Net
Detailed structural and functional "maps" of the human kidney made using advanced scanning technology are to be developed by scientists at The University of Nottingham. The research, funded with $107,623 from the Dr. Hadwen Trust, a non-animal biomedical research charity, aims to further our understanding of how the kidneys function, ultimately leading to better monitoring and treatment for chronic kidney disease. It will be the first of its kind to use magnetic resonance imaging to investigate the role which oxygen plays in keeping the human kidney healthy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Weakness exposed in most common cancer gene
Medical Xpress
NYU Langone Medical Center researchers have found a biological weakness in the workings of the most commonly mutated gene involved in human cancers, known as mutant K-Ras, which they say can be exploited by drug chemotherapies to thwart tumor growth. Mutant K-Ras has long been suspected of being the driving force behind more than a third of all cancers, including colon, lung, and a majority of pancreatic cancers. Indeed, Ras cancers, which are unusually aggressive, are thought of as "undruggable" because every previous attempt to stall their growth has failed.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cetuximab plus chemotherapy effective in NSCLC
Healio
The addition of cetuximab to platinum-based first-line chemotherapy significantly improved outcomes in patients with advanced non–small-cell lung cancer, according to results of a meta-analysis. The regimen also appeared well tolerated. The analysis included data from four randomized phase 2 and 3 trials that examined the addition of cetuximab (Erbitux, Eli Lilly) to platinum-based first-line chemotherapy in 2,018 patients with advanced NSCLC.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cantor makes pitch for increase in childhood disease research
Work it, Richmond
An unusual group of lobbyists met recently with House Majority Leader Eric Cantor, R-7th, to discuss their desire for increased federal research into cures for childhood diseases. Most had to boost their chairs higher to see eye to eye with the congressman as they gathered in a conference room at Kaleo Inc., a Richmond-based biotechnology business. And most had skipped school to meet with Cantor.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword RESEARCH.


Are advanced imaging technologies worth the risks?
By Denise A. Valenti
The use of advanced imaging technologies — MRIs and CT scans — increased more than threefold between the years 2000 and 2010. Noninvasive diagnostic technologies can lead to earlier and more precise diagnosis of pathology, but they also come with an increased cost and sometimes with a danger of exposure to ionizing radiation. The risk of incurring cancer from the radiation exposure with CT is small, but it is not zero. With more than 85 million scans performed yearly in the United States, do the benefits outweigh the risks?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Progress in stem cell biology: This could change everything about the practice of medicine (MedCityNews)
Check out the NSH Meeting Calendar! (NSH)
New study raises questions about antioxidant use in lung cancer patients (The Washington Post)
Unnecessary medical radiation driving up US cancer rates, 2 physicians say (MinnPost)
30 years later: Are we any closer to a cure for AIDS? (By Dorothy L. Tengler)

Don't be left behind. Click here to see what else you missed.
 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Feb 11, 2014 blast
Feb. 5, 2014
Jan 31, 2014 blast
Jan. 29, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063